While ASS1 expression did not correlate with BCT-100 IC50 in neuroblastoma cell lines, upregulation of ASS1/ASL/OTC was observed in some BCT-100 treated Th-MYCN tumors. The gene discussed is ASL; the disease is neuroblastoma.